세계의 극외측 추체간 고정술(XLIF) 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Extreme Lateral Interbody Fusion (XLIF) Surgery Market is presumed to reach the market size of nearly USD 1.59 BN by 2030 from USD 1 BN in 2022 with a CAGR of 5.89% under the study period 2023 - 2030.

Extreme Lateral Interbody Fusion (XLIF) is a surgical procedure used to treat certain spinal conditions by accessing the spine from the side (lateral approach). This minimally invasive technique allows surgeons to address issues such as degenerative disc disease, disc herniation, or instability of the spine without the need for traditional posterior or anterior approaches.

MARKET DYNAMICS

The extreme lateral interbody fusion surgery market is fueled by the demand for minimally invasive spinal procedures and advancements in spinal surgery techniques. Offering a less invasive alternative to traditional spinal surgeries, this procedure is preferred by patients for its potential benefits, including shorter recovery times and reduced postoperative pain. The aging global population contributes to the increasing incidence of degenerative spinal conditions, driving the demand for XLIF procedures. Ongoing technological advancements in surgical technologies and imaging, along with its adoption by surgeons, enhance the precision and safety of the procedure. Patient preferences for minimally invasive options align with XLIF surgery, further boosting its popularity. Favorable reimbursement policies, positive clinical outcomes, and evidence supporting XLIF's efficacy contribute to its acceptance within the medical community.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of extreme lateral interbody fusion (xlif) surgery. The growth and trends of extreme lateral interbody fusion (xlif) surgery industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the extreme lateral interbody fusion (xlif) surgery market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By End-User

• Spinal Surgery Centers
• Hospitals
• Others

By Product Type

• XLIF Interbody Fusion Systems
• XLIF Interbody Cages

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Extreme Lateral Interbody Fusion (XLIF) Surgery market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Extreme Lateral Interbody Fusion (XLIF) Surgery market include Medtronic plc, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc., NuVasive Inc., Globus Medical Inc., DePuy Synthes, B. Braun Melsungen AG, Alphatec Holdings Inc., RTI Surgical Holdings Inc., K2M Group Holdings Inc., Orthofix Medical Inc., Aesculap Implant Systems, SpineWave Inc., MicroPort Scientific Corporation, Life Spine Inc., Captiva Spine Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . EXTREME LATERAL INTERBODY FUSION (XLIF) SURGERY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By End-User
  • 3.7.2 Market Attractiveness Analysis By Product Type
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL EXTREME LATERAL INTERBODY FUSION (XLIF) SURGERY MARKET ANALYSIS BY END-USER

• 5.1 Overview by End-User
• 5.2 Historical and Forecast Data
• 5.3 Analysis by End-User
• 5.4 Spinal Surgery Centers Historic and Forecast Sales by Regions
• 5.5 Hospitals Historic and Forecast Sales by Regions
• 5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL EXTREME LATERAL INTERBODY FUSION (XLIF) SURGERY MARKET ANALYSIS BY PRODUCT TYPE

• 6.1 Overview by Product Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product Type
• 6.4 XLIF Interbody Fusion Systems Historic and Forecast Sales by Regions
• 6.5 XLIF Interbody Cages Historic and Forecast Sales by Regions

7 . GLOBAL EXTREME LATERAL INTERBODY FUSION (XLIF) SURGERY MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. South East Asia Sales Analysis
  • 7.5.10. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE EXTREME LATERAL INTERBODY FUSION (XLIF) SURGERY COMPANIES

• 8.1. Extreme Lateral Interbody Fusion (Xlif) Surgery Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF EXTREME LATERAL INTERBODY FUSION (XLIF) SURGERY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Medtronic plc
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Johnson & Johnson
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Stryker Corporation
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Zimmer Biomet Holdings Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. NuVasive Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. Globus Medical Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. DePuy Synthes
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. B. Braun Melsungen AG
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. Alphatec Holdings Inc.
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments
• 9.12. RTI Surgical Holdings Inc.
  • 9.12.1. Company Overview
  • 9.12.2. Company Revenue
  • 9.12.3. Products
  • 9.12.4. Recent Developments
• 9.13. K2M Group Holdings Inc.
  • 9.13.1. Company Overview
  • 9.13.2. Company Revenue
  • 9.13.3. Products
  • 9.13.4. Recent Developments
• 9.14. Orthofix Medical Inc.
  • 9.14.1. Company Overview
  • 9.14.2. Company Revenue
  • 9.14.3. Products
  • 9.14.4. Recent Developments
• 9.15. Aesculap Implant Systems
  • 9.15.1. Company Overview
  • 9.15.2. Company Revenue
  • 9.15.3. Products
  • 9.15.4. Recent Developments
• 9.16. SpineWave Inc.
  • 9.16.1. Company Overview
  • 9.16.2. Company Revenue
  • 9.16.3. Products
  • 9.16.4. Recent Developments
• 9.17. MicroPort Scientific Corporation
  • 9.17.1. Company Overview
  • 9.17.2. Company Revenue
  • 9.17.3. Products
  • 9.17.4. Recent Developments
• 9.18. Life Spine Inc.
  • 9.18.1. Company Overview
  • 9.18.2. Company Revenue
  • 9.18.3. Products
  • 9.18.4. Recent Developments
• 9.19. Captiva Spine Inc.
  • 9.19.1. Company Overview
  • 9.19.2. Company Revenue
  • 9.19.3. Products
  • 9.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies